Israel Englander Red Hill Biopharma Ltd. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.14 - $695.9 $13,330 - $66.3 Million	-95,219 Reduced 15.26%	528,673 $74,000
Q3 2022 Nov 14, 2022	BUY	$0.5 - $523.8 $125,481 - $131 Million	250,962 Added 67.29%	623,892 $314,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.58 $234,945 - $962,159	372,930 New	372,930 $324,000
Q1 2022 May 16, 2022	SELL	$1.65 - $3.12 $288,845 - $546,180	-175,058 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.31 - $5.85 $404,383 - $1.02 Million	175,058 New	175,058 $452,000
Q4 2019 Feb 14, 2020	SELL	$5.76 - $7.35 $97,073 - $123,869	-16,853 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$6.46 - $8.37 $315,403 - $408,656	-48,824 Reduced 74.34%	16,853 $118,000
Q2 2019 Aug 15, 2019	SELL	$6.34 - $8.8 $7.43 Million - $10.3 Million	-1,172,193 Reduced 94.69%	65,677 $427,000
Q2 2019 Aug 14, 2019	BUY	$6.34 - $8.8 $7.22 Million - $10 Million	1,139,338 Added 1156.31%	1,237,870 $22.7 Million
Q1 2019 May 14, 2019	SELL	$6.06 - $9.0 $1.23 Million - $1.83 Million	-203,161 Reduced 67.34%	98,532 $819,000
Q4 2018 Feb 14, 2019	BUY	$5.18 - $9.35 $642,692 - $1.16 Million	124,072 Added 69.85%	301,693 $1.67 Million
Q3 2018 Nov 14, 2018	BUY	$6.0 - $11.35 $909,456 - $1.72 Million	151,576 Added 581.98%	177,621 $1.57 Million
Q2 2018 Aug 14, 2018	BUY	$4.82 - $8.53 $75,775 - $134,100	15,721 Added 152.28%	26,045 $222,000
Q1 2018 May 15, 2018	BUY	$4.96 - $6.84 $51,207 - $70,616	10,324 New	10,324 $53,000
Q4 2017 Feb 14, 2018	SELL	$4.58 - $10.81 $89,699 - $211,713	-19,585 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.25 - $10.81 $161,576 - $211,713	19,585	19,585 $212,000

Others Institutions Holding RDHL

# of Institutions

Shares Held

40.4K

Call Options Held

Put Options Held

Eaton Vance Management Boston, MA

40.4K
Shares

$294,639
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About RedHill Biopharma Ltd.

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

More about RDHL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account